DKNG vs EDIT · rev $4.77B vs rev $32.3M
DraftKings Inc (DKNG) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
DraftKings Inc (DKNG) is a gambling company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported DKNG revenue for 2024-12-31 was $4.77B. Net income was -$507.3M. Revenue was up 30.1% from 2023-12-31 to 2024-12-31. DKNG currently screens at market cap $20.96B.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
DKNG currently screens at market cap $20.96B. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the DKNG and EDIT stock pages for the full models.
Not investment advice.